Background and objectives Tuberculosis and COPD are common diseases in developing countries, sharing risk factors like smoking and low socio-economic status but little is known about the specific relationship between tuberculosis and COPD.
Introduction
COPD and tuberculosis mainly affect lungs and are major causes of morbidity and mortality worldwide. Around a third of world population is infected with tuberculosis, with about eight million new cases being reported every year 1 . Prevalence of COPD is increasing. It is estimated that COPD will become the third-leading cause of death by 2020 2 . Both COPD and tuberculosis have common risk factors such as smoking and low socio-economic status 2, 3 . So, it is necessary to know the relationship between tuberculosis and COPD.
This study was conducted in a hospital of southern China where tuberculosis and COPD are among the most common diseases seen in respiratory department. Aims of this study were to investigate any structural changes in lungs as well as to assess any inflammatory and nutritional changes in COPD patients with fibrotic and proliferative Exclusion Criteria: COPD patients with active tuberculosis, occupational lung diseases, asthma, any part of the documented cancer, liver and kidney diseases were all excluded in this study. Statistics: SPSS 16 was used for the analysis. Normality test was done and normal cases were analyzed with independent sample t-test whereas Mann-Whitney test was done for those not following normal distribution. Chisquare test was used for qualitative data. A p value of <0.05 was considered to be statistically significant.
Results
Comparison of bullae or blebs formation in COPD patients with proliferative tuberculosis changes compared to nontuberculosis COPD cases. Out of 84 COPD patients with fibrotic and proliferative tuberculosis changes in chest imaging, 20 (23.8%) of them had significant bullae or blebs in their chest images. But in case of 105 non-tuberculosis COPD cases, obvious bullae were seen only on 11 patients (10.5%) in their chest imaging. Chi Square test was done to compare the incidence of bullae in two groups and it was found that COPD patients with fibrotic and proliferative tuberculosis changes in chest imaging had higher incidence of bullae or blebs compared to non-tuberculosis COPD cases, 
Discussion
Structural changes of lung in COPD patients with fibrotic and proliferative tuberculosis changes compared to nontuberculosis COPD patients.
In this study, there was higher incidence of bullae or blebs in COPD patients with fibrotic and proliferative tuberculosis changes in chest imaging compared to nontuberculosis COPD individuals, Pearson Chi square value 6.05, p=0.014.Tuberculosis can increase the activity of matrix metalloproteinase (MMP) enzymes, similar to that done by smoke exposure, thereby damaging the lung tissue 4 . Increase in activity of MMP enzymes results in destruction of collagen and other internal structures of lung parenchyma. This may result in increased formation of bullae in these groups. Tuberculosis results in scarring of lung tissue and thereby pulls the normal lung tissue towards affected part. This can be the pathological mechanism for increase in bullae formation in tuberculosis infected COPD patients.
Inflammation and nutritional derangement in COPD patients with pulmonary tuberculosis.
To best of our knowledge, this is the first study evaluating inflammation and nutritional status in COPD patients with fibrotic and proliferative tuberculosis changes in chest imaging compared to nontuberculosis COPD cases. It was found that COPD patients with pulmonary tuberculosis infection had higher hsCRP but lower blood iron, albumin, and transferrin compared to COPD patients without tuberculosis.
CRP is an acute phase protein produced by liver under the influence of IL in response to injury or tissue damage. A high sensitivity CRP (hsCRP) measures even low level of CRP. Circulating CRP levels are elevated in blood of stable COPD patients 5 . CRP is also used to predict the prognosis in terms of hazard ratios for hospitalization and death from COPD 6 . In this study, higher hsCRP value in COPD patients with fibrotic and proliferative tubercular changes in chest imaging than COPD patients without pulmonary tuberculosis suggests that there can be greater damage to lung and can have more severe form of COPD leading to poorer prognosis in the former subtype.
In this study, it was found that COPD patients with fibrotic and proliferative tubercular changes in chest imaging had lower blood iron and transferrin value compared to COPD patients without tuberculosis. This can be the scenario of chronic illness. Ratledge had described the role of iron in the pathogenesis of tuberculosis 7 . Host tries to limit infection by lowering iron. But pathogens adapt by increasing the expression of virulence factors and cause damage to the host. Administration of iron in this condition is unfavourable, as increased availability of iron can help the bacteria to multiply. Lower blood iron in COPD patients with proliferative tuberculosis changes can have some protective role in preventing the conversion of this old tuberculosis into active form or it can be due to metabolism of iron in chronic disease. Large scale study is needed to confirm the role of iron in tuberculosis infected COPD patients.
Levels of transferrin decreases in inflammation 8 and is referred as a negative acute phase reactant. Although transferrin is the principal iron binding protein in serum, it is also present in airway mucosa and alveolar lining fluids 9 . Transferrin functions as an antioxidant by tightly binding extracellular iron and thereby inhibiting oxidant induced lipid peroxidation both in serum and lower respiratory tract 10, 11 . It may also have important antibacterial effects in lower respiratory tract by sequestering iron that is needed for bacterial multiplication 12 . Decrease in transferrin level in COPD patients with fibrotic and proliferative tuberculosis changes compared to nontuberculosis COPD cases can therefore point out that there is greater inflammation ongoing in these former patients.
Some studies had shown that there is reduced serum albumin in patient with active tuberculosis [13] [14] [15] . Little is known about albumin level in patients with radiologic features of old pulmonary tuberculosis. Ugur et al reported that serum albumin decreased with decline in lung function 16 . Like transferrin, albumin level decreases during inflammation and is also referred as negative acute phase reactant 8 . In this study, it is found that COPD patients with fibrotic and proliferative tuberculosis changes in their chest imaging had lower blood albumin value compared to COPD patients without tuberculosis. This finding may be due to greater damage in lung leading to more severe inflammation in tuberculosis infected group.
COPD phenotype is a hot topic in recent literatures. It is considered that COPD patient with fibrotic and proliferative tuberculosis changes in chest imaging should be recognized as a new phenotype and should be treated with great caution, as the use of inhaled corticosteroid (as an antiinflammatory treatment) in this subtype carries certain risk of conversion of old tuberculosis into active form. Whether to treat COPD patient with fibrotic and proliferative tuberculosis changes in chest imaging with anti-tuberculosis therapy is also of great concern, making this phenotype to be given greater emphasis in coming days.
In conclusion, COPD patients with fibrotic and proliferative tuberculosis changes in chest imaging had greater inflammation and damage to lung tissue (determined by increase bullae formation, higher hsCRP level) with decrease in basic nutritional elements compared to non-tuberculosis COPD cases.
